- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
News 39 results
Recognition
November 10, 2021
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Seventh Year
In the News · Source: Capital & Main
November 8, 2021
Dixie Johnson, Amanda Sonneborn and Keith Townsend’s client alert that examined the SEC enforcement of human capital disclosures is referenced
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
September 1, 2021
Benchmark Names Three King & Spalding Partners to List of Top 250 Women in Litigation
In the News · Source: Law360
August 24, 2021
Dixie Johnson advises Healthcare Service Group with its settlement with the SEC
Recognition
May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Corporate Crime Reporter
March 3, 2021
Corporate Crime Reporter profiles Dixie Johnson who discusses internal investigations, SEC whistleblowing and self reporting
Recognition
October 29, 2020
Securities Docket Names Carmen Lawrence, Dixie Johnson and Richard Walker to Enforcement 40 List
Recognition
October 23, 2020
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Sixth Year
Recognition
October 15, 2020
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
In the News · Source: Law360
June 16, 2020
Dixie Johnson advises Wells Fargo on its residential mortgage-backed securities settlement with the state of Maryland